Creative Details

Quality Score: N/A

The advertisement promotes the availability of Zepbound, a tirzepatide injection, and encourages viewers to discover the clinical trial data and results.

Creative Information

CID:	41642950-b9ee-45ef-bf29-97fa65d78de8
CRID:	29_650979858
Domain:	pathtosuccess.global
Seat:	Xandr
Size:	300x250
Bid:	$0.25
Timestamp:	10/30/2025, 2:26:31 PM
Declared IAB Categories:

Analysis

4 succeeded1 failed(80% complete)

Task	Status	Last Updated	Duration
ad_analysis	failed	12/10/2025, 1:45:22 AM	5.55s
adomain_analysis	success	11/13/2025, 7:18:48 PM	3.26s
adomain_capture	success	11/13/2025, 7:18:45 PM	0.14s
ad_render	success	11/13/2025, 7:19:03 PM	9.83s
brand_mapping	success	11/13/2025, 7:18:46 PM	1.41s

Analysis Results

Ad Format: banner

Brands:

Size:

300x250

Data Transferred:

1478.85 KB

Render Time:

8.43 Seconds

Total Ad Size:

1478.89 KB

Requests Made:

URL	Size (KB)
https://cdn.doubleverify.com/dvbm.js	527.94
https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js	222.95
https://adsdkprod.azureedge.net/viewability/versions/v5.8.22/banner.js	152.75
https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js	116.69
https://ad.doubleclick.net/ddm/adj/N6275.5199567ADDAPTIVEINTELLIGEN/B33725440.425093503;dc_ver=106.314;dc_eid=40004001;sz=300x250;u_sd=1;gdpr=0;nel=1;dc_adk=2027040026;ord=9k0m2q;click=https%3A%2F%2Flax1-ib.adnxs.com%2Fclick2%3Fe%3DwqT_3QKkAfBDpAAAAAMAxBkFAQjwxtTIBhCgqtO074_rxxwYou3oi8iou8F7IPDOogwo7T8wuwY4AkCS1LS2AkiVlZsBUABaA1VTRGIBBfBbaKwCcPoBeN_5aIAB7_8FiAEBkAECmAEFoAECqQFvsRNcJ8W9P7EBrOC3IcZruj-5AQAAAEAK1x5AwQHxvFRszGu6P8kBMBLaci7FvT_YAZynA-ABAPAB_wH4AQA.%2Fs%3Db908c1fb83a74b276e15a95daacc8f5b2e5c5807%2Fbcr%3DAAAAAAAA8D8%3D%2Fcnd%3D%2521jhFb-wjmufUeEJLUtLYCGJWVmwEgACgAMQAAAAAAAAxAOglMQVgxOjYzMDVA1UpJAAAAAAAA8D9RAAAAAAAAAABZAAAAAAAAAABhAAAAAAAAAABpAAAAAAAAAABxAAAAAAAAAAB4AIkBAAAAAAAA8D8.%2Fcca%3DODI3I0xBWDE6NjMwNQ%3D%3D%2Fbn%3D98287%2Fclickenc%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=7vEHSVIXw9;gcsr=m;stc=1;chaa=1;sttr=39;prcl=s	101.55
https://s0.2mdn.net/sadbundle/16832360008301944586/TIR_HCP_NowAvail_300x250/edge.5.0.1.min.js	101.46
https://www.googletagservices.com/dcm/impl_v106.js	68.78
https://ep1.adtrafficquality.google/bg/DPVnEqOOr8GEkyz-5oBqyWDy70NS1PVNM5rSU7EcCeQ.js	52.04
https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js	42.74
https://s0.2mdn.net/sadbundle/16832360008301944586/TIR_HCP_NowAvail_300x250/images/cta.png	26.80

Advertiser Domain

Ad Preview

Raw Ad Markup

<script src="https://lax1-ib.adnxs.com/ab?an_audit=0&referrer=https%3A%2F%2Fcanucksarmy.com%2Fnews%2Fwhere-lekkerimaki-mancini-fit-vancouver-canucks-lineup-when-return&e=wqT_3QK-EfBMvggAAAMA1gAFAQjwxtTIBhCgqtO074_rxxwYou3oi8iou8F7KjYJMRLaci7FvT8R8bxUbMxruj8ZAAAAQArXHkAh8bxUbMxruj8pMBIJJNAxAAAAANejAkAw8M6iDDjtP0C7BkgCUJLUtLYCWJWVmwFgAGjf-Wh47_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-HBUKCFNQTElUAU0Z2vQOAYADAIgDAZADAJgDFKADAaoDAkgAwAPYBMgDANgDl4Y24AMA6AMB-AMDgAQAkgQJL29wZW5ydGIymAQAogQMMTc0LjQuMTMyLjU0qATZjQuyBA4IABAAGAAgADAAOABCALgEAMAEAMgEANIEDTgyNyNMQVgxOjYzMDXaBAIIAeAEAPAEktS0tgKIBQGYBQCgBf___________wGqBSQ1ZGVjZTU4Ni03NGZiLTRiN2YtODYwMy1mNjVkZGNlMDRkYmbABQDJBQAAAAAAAPA_0gUJCQAAAAAAAAAA2AUB4AUB8AWb24EB-gUECAAQAJAGAJgGALgGAMEGAAAAAAAA8D_QBv8B2gYWChAAAAAAAADhKgkBcBAAGADgBgHyBgIIAIAHAYgHAKAHAcgH7_8F0gcPFWUBJhQgANoHBggFC_QAAeAHAOoHAggA8AfIgN8SigjDAQq-AQAAAZp6km2AHI-sfvaU1SDngSvVsVeWtgBxwr6WEyV2fvUEAcjbqR2_SQ3lfcwy9TMJiN0jB2k6MviktnOO7sONAy1hoiuv-Ja0PjJuHaf5X0wOfROuQpoWHMHpIfEKj_Hy9HpI3Hy2w4Uzup07Os7mJqjGx2VRdceNdMNOyDJXDFs2VXo6JQiC0EHH_bu28uQmINNX42_fPsAeVtfrA-uXv0o_h_tCx_8sm2jp7J7HcrzN0cHlmSU8HGNYAn8QAZUIAACAP5gIAsAInKcD0ggOCIGChIiQoMCAARAAGADaCAQIACAA4AgA6AgA&s=e72e078dcfbd762172d8cde4bb4490a3398c8c25&pp=0.103207"></script>

Creatives